Probiotics, defined as live microorganisms that confer health benefits when consumed in adequate amounts, have garnered attention for their potential to influence the gut-brain axis
While the original trials conducted by Palatin Technologies and others focused on female populations, subsequent observational data and patient outcomes from institutions like Boston Medical Group provide valuable insights into its tolerability and impact in men
Drawing multiple peptides into one syringe reduces injection burden without compromising effectiveness
While peptides offer promising benefits, they can also have potential side effects that may affect an individuals health and well-being, such as allergic reactions or interactions with other medications
SS-31 (elamipretide) , a mitochondria-targeted peptide that stabilizes cardiolipin to support energy production, became the first FDA-approved mitochondrial therapeutic in 2025, though only for the rare Barth syndrome, with the brain rationale still mechanistic and no cognitive trials
